This discovery not only highlights the important role of the p300-JMJD1A axis in PCa but also provides a new potential therapeutic target for CRPC, further emphasizing the key role of epigenetic regulation in tumor development. This evidence concerns the gene KDM3A and posterior cortical atrophy.